Evidence map›Paper›PMID 2671994›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1989

The noncovalent complex between DNA and the bifunctional intercalator ditercalinium is a substrate for the UvrABC endonuclease of Escherichia coli.

B Lambert, B K Jones, B P Roques, J B Le Pecq, A T Yeung

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1989. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 34 citations in OpenAlex.

  1. Recent Advances in Developing Small Molecules Targeting Nucleic Acid.International journal of molecular sciences · 2016
    Review
  2. Review
  3. Article
  4. Article
  5. The C-terminal half of UvrC protein is sufficient to reconstitute (A)BC excinuclease.Proceedings of the National Academy of Sciences of the United States of America · 1991
    Article
  6. Drug-induced DNA repair: X-ray structure of a DNA-ditercalinium complex.Proceedings of the National Academy of Sciences of the United States of America · 1991
    Article
  7. Molecular mechanisms of DNA repair inhibition by caffeine.Proceedings of the National Academy of Sciences of the United States of America · 1990
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

B LambertUnité de Physicochimie Macromoléculaire, URA 158 Centre National de la Recherche Scientifique, Institut Gustave Roussy, Villejuif, France.
B K Jones
B P Roques
J B Le Pecq
A T Yeung
Institut Gustave Roussy · FR

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
NCI NIH HHS CA06927NCRR NIH HHS RR05539
6 · The paper itself

Abstract

We have demonstrated that the noncovalent complex formed between DNA and an antitumor bifunctional intercalator, ditercalinium, is recognized in vitro as bulky covalent DNA lesions by the purified Escherichia coli UvrABC endonuclease. It was established that no covalent drug-DNA adduct was formed during the incubation of the drug with DNA or during subsequent incubation with the UvrAB proteins. The nucleoprotein-ditercalinium complexes appear different from those generated by repair of pyrimidine dimers. The UvrA protein is able to form a stable complex with ditercalinium-intercalated DNA in the presence of ATP, whereas both UvrA and UvrB proteins are required to form a stable complex with pyrimidine dimer-containing DNA. The apparent half-life of the UvrA- and UvrAB-ditercalinium-DNA complexes following removal of free ditercalinium is 5 min. However, if the free ditercalinium concentration is maintained to allow the intercalation of one molecule of ditercalinium per 3000 base pairs, the half-life of the UvrA- or UvrAB-ditercalinium-DNA complex is 50 min, comparable to that of the complex of UvrAB proteins formed with pyrimidine dimer-containing DNA. UvrABC endonuclease incises ditercalinium-intercalated DNA as efficiently as pyrimidine dimer-containing DNA. However, unlike repair of pyrimidine dimers, the incision reaction is strongly favored by the supercoiling of the DNA substrate. Because UvrA- or UvrAB-ditercalinium-DNA complexes can be formed with relaxed DNA without leading to a subsequent incision reaction, these apparently dead-end nucleoprotein complexes may become lesions in themselves resulting in the cytotoxicity of ditercalinium. Our results show that binding of excision repair proteins to a noncovalent DNA-ligand complex may lead to cell toxicity.

Indexed as

Escherichia coli ProteinsPlasmidsAntineoplastic AgentsCarbazolesEndodeoxyribonucleasesEscherichia coliIntercalating AgentsKineticsProtein BindingSubstrate SpecificityAntineoplastic AgentsCarbazolesditercaliniumEndodeoxyribonucleasesendodeoxyribonuclease uvrABCEscherichia coli ProteinsIntercalating Agents

Identifiers

PMID2671994
PMCPMC297883
OpenAlexW2014509983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.